Descripción del proyecto
Nuevas tecnologías ópticas para mejorar la visión durante el envejecimiento
Las enfermedades oculares que limitan la visión se suelen asociar al proceso de envejecimiento. Mantener una buena visión a lo largo de la vida es fundamental, sobre todo para la población europea que envejece. El diagnóstico temprano de las enfermedades oculares es esencial para administrar un tratamiento oportuno y reducir el riesgo de pérdida de visión. El proyecto ACTIVA, financiado con fondos europeos, es una plataforma interdisciplinar concebida para formar a nueve jóvenes investigadores en tecnologías emergentes de diagnóstico y tratamiento de trastornos oculares relacionados con el envejecimiento. Estos investigadores abordarán cuestiones sin resolver y desarrollarán técnicas innovadoras para mejorar o preservar la función visual en la población de mayor edad. El proyecto se centrará en la creación de tecnologías ópticas para mejorar la visión a lo largo de toda la vida, mejorando la visión de cerca y de lejos y facilitando la detección temprana de enfermedades.
Objetivo
The proposed DN “Advanced Customized Technologies for Intact Vision in Ageing” (ACTIVA) provides an international, interdisciplinary platform to train young scientists at the interface of physics and medicine to study unresolved questions and develop novel techniques to facilitate intact, or even improved, visual function in the elderly population. Good vision throughout life is a key factor both on a personal level and socioeconomically and has particular pertinence to the ageing population of Europe.
ACTIVA is a joint initiative to develop new optical technologies that will facilitate good vision throughout life. Within the project, 9 young researchers will be trained in new optical technologies to diagnose and compensate for different aspects of the normal ageing of the eye as well as the most common age-related ocular conditions. The novel vision enabling techniques, to be developed in this DN, will focus on facilitating the functionality of both near and far vision. Furthermore, early diagnosis of ocular diseases is essential to offer timely treatment and reduce the risk of vision loss. The novel diagnosis technologies, to be developed in this DN, will focus on early detection of pathological changes in visual function.
The consortium combines the expertise of three academic partners with excellent research and teaching records and two fully integrated private sector partners. Furthermore, the consortium will be counselled by a scientifically accomplished External Advisory Board. Close collaborations and multi-site training activities will ensure to provide the young researchers with a vast network and interdisciplinary research experience. ACTIVA will be recognized worldwide as a major contribution to the ageing challenge and the social investment of the European Commission in active ageing.
Ámbito científico
Palabras clave
Programa(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Régimen de financiación
HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral NetworksCoordinador
100 44 Stockholm
Suecia